Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant Expects Similar 20% Penetration Of Expanded ICD Market Via MADIT

This article was originally published in The Gray Sheet

Executive Summary

Guidant projects the U.S. implantable defibrillator market will double to about $2.8 bil. as the applicable patient population expands based on indications evaluated in its recent MADIT II study. A related Guidant ICD PMA supplement was submitted in December 2001

Related Content

UsernamePublicRestriction

Register

MT015941

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel